These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6779059)

  • 1. The Mayo three-community hypertension control program. V. Cost-effectiveness of intervention.
    Christianson JB; Krishan I; Nobrega FT; Davis CS; Smoldt RK; Harris AM
    Mayo Clin Proc; 1981 Jan; 56(1):11-6. PubMed ID: 6779059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mayo three-community hypertension control program. IV. Five-year outcomes of intervention in entire communities.
    Krishan I; Davis CS; Nobrega FT; Smoldt RK
    Mayo Clin Proc; 1981 Jan; 56(1):3-10. PubMed ID: 7453248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mayo Three-Community Hypertension Control Program. I. Design and initial screening results.
    Labarthe DR; Krishan I; Nobrega FT; Brennan LA; Smoldt RK; Mori HD; Hunt JC
    Mayo Clin Proc; 1979 May; 54(5):289-98. PubMed ID: 431130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness and budget impact analyses of a long-term hypertension detection and control program for stroke prevention.
    Yamagishi K; Sato S; Kitamura A; Kiyama M; Okada T; Tanigawa T; Ohira T; Imano H; Kondo M; Okubo I; Ishikawa Y; Shimamoto T; Iso H;
    J Hypertens; 2012 Sep; 30(9):1874-9. PubMed ID: 22796712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The analysis of drug cost and direct medical expense in community health management of hypertensive patients].
    Liang XH; Gu DF; Zhang H; Zhu K; Deng Y; Cao J; Zhou ZY; Wang Y; Wan GS; Zhao C; Mu QC; Lu FH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):732-6. PubMed ID: 22169696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mayo Three-Community Hypertension Control Program. II. Outcome of intervention in entire communities.
    Krishan I; Brennan LA; Nobrega FT; Smoldt RK; Smutka LK; Labarthe DR; McEnaney JA; Hunt JC
    Mayo Clin Proc; 1979 May; 54(5):299-306. PubMed ID: 431131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the variation in costs among HIV primary care providers.
    Gilman BH; Green JC
    AIDS Care; 2008 Oct; 20(9):1050-6. PubMed ID: 18825514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and benefits of community programmes for the control of hypertension.
    Nissinen A; Tuomilehto J; Enlund H; Kottke TE
    J Hum Hypertens; 1992 Dec; 6(6):473-9. PubMed ID: 1296012
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic analysis of the diabetes and hypertension screening collaboration between community pharmacies and a Thai government primary care unit.
    Sookaneknun P; Saramunee K; Rattarom R; Kongsri S; Senanok R; Pinitkit P; Sawangsri W; Deesin B
    Prim Care Diabetes; 2010 Oct; 4(3):155-64. PubMed ID: 20558122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A national hypertension treatment program in Germany and its estimated impact on costs, life expectancy, and cost-effectiveness.
    Gandjour A; Stock S
    Health Policy; 2007 Oct; 83(2-3):257-67. PubMed ID: 17335933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of community-based treatment of severe acute malnutrition in children.
    Bachmann MO
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):605-12. PubMed ID: 20950075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of costs and effectiveness of an integrated outpatient training program for hypertensive patients].
    Kurz RW; Pirker H; Pötz H; Dörrscheidt W; Uhlir H
    Wien Klin Wochenschr; 2005 Aug; 117(15-16):526-33. PubMed ID: 16158203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of a community-based approach intertwined with a vertical Aedes control program.
    Baly A; Toledo ME; Vanlerberghe V; Ceballos E; Reyes A; Sanchez I; Carvajal M; Maso R; La Rosa M; Denis O; Boelaert M; Van der Stuyft P
    Am J Trop Med Hyg; 2009 Jul; 81(1):88-93. PubMed ID: 19556572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mayo Three-Community Hypertension Control Program. III. Outcome in a community-based hypertension clinic.
    Brennan LA; Krishan I; Nobrega FT; Labarthe DR; Timm ME; McGrath JV; Sheps SG; Hunt JC
    Mayo Clin Proc; 1979 May; 54(5):307-12. PubMed ID: 431132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis of a tailored behavioral intervention to improve blood pressure control for primary care patients.
    Datta SK; Oddone EZ; Olsen MK; Orr M; McCant F; Gentry P; Bosworth HB
    Am Heart J; 2010 Aug; 160(2):257-63. PubMed ID: 20691830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic analysis of a school-based obesity prevention program.
    Wang LY; Yang Q; Lowry R; Wechsler H
    Obes Res; 2003 Nov; 11(11):1313-24. PubMed ID: 14627751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pursuing cost-effectiveness in mental health service delivery for youth with complex needs.
    Grimes KE; Schulz MF; Cohen SA; Mullin BO; Lehar SE; Tien S
    J Ment Health Policy Econ; 2011 Jun; 14(2):73-83. PubMed ID: 21881163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of angiotensin receptor blocker monotherapy in patients with hypertension in the Netherlands: a comparative analysis using clinical trial and drug utilization data.
    Boersma C; Voors AA; Visser ST; de Jong-van den Berg LT; Postma MJ
    Am J Cardiovasc Drugs; 2010; 10(1):49-54. PubMed ID: 20104934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic appraisal of a community-wide cardiovascular health awareness program.
    Goeree R; von Keyserlingk C; Burke N; He J; Kaczorowski J; Chambers L; Dolovich L; Michael Paterson J; Zagorski B
    Value Health; 2013; 16(1):39-45. PubMed ID: 23337214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.